Optipharm.CO.,LTD (KOSDAQ:153710)

Optipharm.CO.,LTD Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	1,986	3,622	2,254	5,573	8,187	15,725
Short-Term Investments	8,773	10,610	13,396	11,048	13,919	6,444
Cash & Short-Term Investments	10,759	14,231	15,651	16,621	22,106	22,169
Cash Growth	-28.61%	-9.07%	-5.84%	-24.81%	-0.28%	-13.11%
Accounts Receivable	1,428	1,089	1,369	1,124	1,001	863.24
Other Receivables	1,066	274.01	268.86	972.95	173.3	172.83
Receivables	2,579	1,498	1,783	2,231	1,314	1,235
Inventory	1,929	1,313	1,320	1,099	1,056	716.88
Prepaid Expenses	156.58	303.42	327.28	316.77	497.53	981.89
Other Current Assets	1,453	1,329	1,395	1,279	893.95	573.7
Total Current Assets	16,876	18,675	20,476	21,548	25,867	25,676
Property, Plant & Equipment	24,958	23,789	18,325	17,717	13,613	13,347
Long-Term Investments	-0	0	0	985.74	986.09	986.39
Other Intangible Assets	269.31	295.01	281.51	258.4	263.82	272.36
Other Long-Term Assets	216.05	559.74	193.34	673.72	438.74	1,040
Total Assets	42,319	43,319	39,275	41,182	41,168	41,321
Accounts Payable	677.85	405.39	581.26	503.35	575.04	383.31
Accrued Expenses	303.23	445.72	437.63	101.92	76.1	68.29
Short-Term Debt	10,310	10,750	9,610	7,470	5,830	4,290
Current Portion of Leases	138.34	124.85	148.32	90.25	102.31	10.88
Current Unearned Revenue	861.58	47.43	-	-	-	-
Other Current Liabilities	841.77	960.28	823.69	1,098	1,267	771.7
Total Current Liabilities	13,133	12,734	11,601	9,264	7,851	5,524
Long-Term Leases	139.88	133.84	287.95	164.08	47.15	179.84
Long-Term Unearned Revenue	763.25	853.11	887.03	1,146	324.51	225.72
Pension & Post-Retirement Benefits	1,431	1,123	1,314	1,559	1,953	1,580
Long-Term Deferred Tax Liabilities	1,094	1,094	-	-	-	-
Other Long-Term Liabilities	51.12	45.8	41.08	38.74	37.91	31.38
Total Liabilities	16,611	15,983	14,131	12,171	10,213	7,541
Common Stock	7,335	7,335	7,335	7,335	7,295	7,237
Additional Paid-In Capital	44,031	44,031	41,982	41,982	41,710	41,211
Retained Earnings	-29,991	-27,835	-25,299	-22,404	-20,243	-16,990
Comprehensive Income & Other	4,333	3,805	1,127	2,098	2,193	2,321
Shareholders' Equity	25,708	27,335	25,144	29,011	30,955	33,780
Total Liabilities & Equity	42,319	43,319	39,275	41,182	41,168	41,321
Total Debt	10,588	11,009	10,046	7,724	5,979	4,481
Net Cash (Debt)	170.73	3,223	5,605	8,897	16,126	17,688
Net Cash Growth	-95.63%	-42.50%	-37.00%	-44.83%	-8.83%	-19.43%
Net Cash Per Share	11.64	219.68	381.82	609.19	1110.10	1225.67
Filing Date Shares Outstanding	14.79	14.67	14.67	14.67	14.59	14.47
Total Common Shares Outstanding	14.79	14.67	14.67	14.67	14.59	14.47
Working Capital	3,743	5,941	8,875	12,284	18,016	20,151
Book Value Per Share	1738.31	1863.36	1714.00	1977.60	2121.75	2333.75
Tangible Book Value	25,439	27,040	24,863	28,753	30,691	33,507
Tangible Book Value Per Share	1720.10	1843.25	1694.81	1959.99	2103.67	2314.93
Land	8,816	8,816	3,583	3,583	3,583	3,583
Buildings	17,222	14,380	14,380	10,936	10,403	10,392
Machinery	9,191	9,115	8,220	6,909	5,776	5,224
Construction In Progress	-	809.03	-	3,128	573.74	12.4

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.